0000950170-24-025870.txt : 20240305
0000950170-24-025870.hdr.sgml : 20240305
20240305160521
ACCESSION NUMBER: 0000950170-24-025870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Germa Caroline
CENTRAL INDEX KEY: 0002013288
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40287
FILM NUMBER: 24720251
MAIL ADDRESS:
STREET 1: IKENA ONCOLOGY, INC.
STREET 2: 645 SUMMER STREET, SUITE 101
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ikena Oncology, Inc.
CENTRAL INDEX KEY: 0001835579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-343-8292
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
ownership.xml
4
X0508
4
2024-03-01
0001835579
Ikena Oncology, Inc.
IKNA
0002013288
Germa Caroline
C/O IKENA ONCOLOGY, INC.
645 SUMMER STREET, SUITE 101
BOSTON
MA
02210
false
true
false
false
Chief Medical Officer
false
Stock Option (Right to Buy)
1.47
2024-03-01
4
A
false
579100
0.00
A
2034-03-01
Common Stock
579100
579100
D
12.5% of the shares subject to this option shall vest and become exercisable on September 1, 2024, with the remainder vesting in forty-two (42) equal monthly installments thereafter.
/s/ Mark Manfredi, as Attorney-in-Fact for Caroline Germa
2024-03-05